Nu Skin Enterprises (NYSE:NUS) Releases Q3 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its third quarter 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.100-0.200 for the period, compared to the consensus earnings per share estimate of 0.320. The company issued revenue guidance of $310.0 million-$340.0 million, compared to the consensus revenue estimate of $375.5 million. Nu Skin Enterprises also updated its FY 2026 guidance to 0.700-0.900 EPS.

Nu Skin Enterprises Stock Down 6.0%

Shares of Nu Skin Enterprises stock traded down $0.33 during midday trading on Monday, hitting $5.16. The company’s stock had a trading volume of 972,182 shares, compared to its average volume of 593,556. Nu Skin Enterprises has a 1-year low of $4.89 and a 1-year high of $14.62. The company has a quick ratio of 1.34, a current ratio of 2.03 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $250.52 million, a P/E ratio of 4.69 and a beta of 0.98. The stock has a 50-day simple moving average of $5.22 and a 200-day simple moving average of $6.98.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.20 EPS for the quarter, meeting the consensus estimate of $0.20. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. The business had revenue of $320.11 million for the quarter, compared to analysts’ expectations of $345.20 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. As a group, sell-side analysts expect that Nu Skin Enterprises will post 1 earnings per share for the current year.

Analyst Upgrades and Downgrades

NUS has been the topic of a number of recent research reports. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research note on Monday, April 13th. Weiss Ratings lowered Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Nu Skin Enterprises has a consensus rating of “Reduce”.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Corient Private Wealth LLC acquired a new stake in Nu Skin Enterprises in the 4th quarter worth approximately $166,000. Invesco Ltd. grew its holdings in Nu Skin Enterprises by 15.9% during the fourth quarter. Invesco Ltd. now owns 85,975 shares of the company’s stock valued at $827,000 after purchasing an additional 11,810 shares during the last quarter. State of Tennessee Department of Treasury grew its holdings in Nu Skin Enterprises by 165.2% during the fourth quarter. State of Tennessee Department of Treasury now owns 30,835 shares of the company’s stock valued at $327,000 after purchasing an additional 19,210 shares during the last quarter. EP Wealth Advisors LLC bought a new position in shares of Nu Skin Enterprises in the fourth quarter valued at approximately $692,000. Finally, Empowered Funds LLC raised its position in shares of Nu Skin Enterprises by 45.0% in the fourth quarter. Empowered Funds LLC now owns 241,670 shares of the company’s stock valued at $2,325,000 after purchasing an additional 74,945 shares during the period. 82.84% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.